Posts by rw-admin
FDA Clears Siemens’ Cios Flow Mobile C-arm System
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Cios Flow, a mobile C-arm designed for use by multiple disciplines in the operating room (OR) – including orthopedics, trauma surgery, spinal surgery, vascular surgery, and pain therapy – to increase the ease and efficiency of everyday imaging workflows for surgical interventions.…
Read MoreSTERIS Spending $4.6B to Acquire Cantel Medical
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers. Under the terms of the agreement, STERIS will…
Read MoreItamar Medical Acquires Technology and Assets of Spry Health
Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea Adds the capability to monitor the longer-term accumulated disease burden of sleep apnea to complement the single night diagnostics commonly used today, including the Company’s existing WatchPAT™ device Paves the way…
Read MoreLocate Bio’s CognitOss Lands FDA Breakthrough Device Designation
Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to CognitOss, currently in development for the treatment of chronic osteomyelitis. The FDA Breakthrough Device Program is intended to help patients receive more timely access to certain technologies that have…
Read MoreHologic to Makes Second Major Acquisition of 2021, Acquires Biotheranostics for $230M
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. “Acquiring Biotheranostics enables us to jump-start our…
Read MoreStryker Acquires OrthoSensor, Adds Knee Surgery Sensor Technology to Portfolio
Stryker announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. “Smart devices and implants will play a big role in orthopaedics and we are excited…
Read MoreHologic to Acquire Somatex Biopsy Site Marker Technology for $64 Million
Hologic (NSDQ:HOLX) announced today that it completed the acquisition of Somatex Medical Technologies GmbH for $64 million. Marlborough, Mass.-based Hologic’s acquisition of the company, which was previously owned by E-Med Solutions GmbH, is slated to support its strategy of providing further solutions across the continuum of breast health care and across Europe, according to a news release. Somatex’s…
Read MorePhilips to Acquire BioTelemetry in $2.8B Deal
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that they have entered into a definitive merger agreement with Royal Philips (NYSE: PHG, AEX: PHIA). Royal Philips, a global leader in health technology, and BioTelemetry, Inc., a…
Read MoreMiach Orthopaedics’ ACL Tear Device Granted FDA De Novo Approval
Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that the U.S. Food & Drug Administration has granted the company’s De Novo Request for the Bridge-Enhanced® ACL Repair (BEAR®) Implant, resulting in marketing approval for the treatment of anterior cruciate ligament (ACL) tears, one of the…
Read MorePhilips and Insightec Teaming Up on Ultrasound for Neurosurgery
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and InSightec, a global healthcare company focused on the therapeutic power of acoustic energy, today announced a collaboration to expand access to MR-guided focused ultrasound for incisionless neurosurgery. By developing compatibility between Philips’ advanced MR systems and the Exablate Neuro platform from InSightec, the two…
Read More